Early response monitoring of receptor tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma using [F-18]fluorothymidine-positron emission tomography-magnetic resonance. [electronic resource]
Producer: 20150825Description: 238-41 p. digitalISSN:- 1558-4658
- Antineoplastic Agents -- therapeutic use
- Carcinoma, Renal Cell -- diagnosis
- Contrast Media
- Diffusion Magnetic Resonance Imaging
- Gadolinium DTPA
- Humans
- Image Enhancement
- Indoles -- therapeutic use
- Kidney Neoplasms -- diagnosis
- Magnetic Resonance Spectroscopy
- Male
- Middle Aged
- Multimodal Imaging
- Positron-Emission Tomography
- Protein Kinase Inhibitors -- therapeutic use
- Pyrroles -- therapeutic use
- Radiopharmaceuticals
- Sunitinib
- Tomography, X-Ray Computed
- Treatment Outcome
- Tyrosine -- analogs & derivatives
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.